用于治疗成人部分发作性癫痫新药-cenobamate

A new drug in treating adults with partial-onset seizures-cenobamate

Cenobamate(YKP-3089)是一种治疗部分发作癫痫的药物,该药于2019年11月21日获得美国食品药品管理局(FDA)批准上市,商品名:XCOPRI,用于治疗成人部分发作性癫痫病。本文就cenobamate的用法用量、作用机制、临床研究、药动学、药物相互作用、不良反应及安全性作一介绍。

Cenobamate(YKP-3089)is a drug for the treatment of partial epilepsy.The drug was approved by the US Food and Drug Administration(FDA)on November 21,2019 and is marketed as XCOPRI to be used for adult patients.This article introduces the usage and dosage of cenobamate,its mechanism of action,clinical research,pharmacokinetics,drug interaction,adverse reactions and safety.